Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Coleman, Jamie J.
and
Martin, Una
2006.
Drug-induced systemic hypertension.
Adverse Drug Reaction Bulletin,
Vol. &NA;,
Issue. 239,
p.
915.
Toro-Chico, P.
Gil Navarro, I.
and
Pérez Encinas, M.
2006.
Sindrome neuroléptico maligno asociado a antidepresivos tricíclicos.
Farmacia Hospitalaria,
Vol. 30,
Issue. 4,
p.
261.
Huang, Vanthida
and
Gortney, Justine S
2006.
Risk of Serotonin Syndrome with Concomitant Administration of Linezolid and Serotonin Agonists.
Pharmacotherapy,
Vol. 26,
Issue. 12,
p.
1784.
Courey, Tamra J.
and
McIntyre, Lora J.
2006.
The nurse practitioner's role in early detection and management of neuroleptic malignant syndrome.
The Journal for Nurse Practitioners,
Vol. 2,
Issue. 7,
p.
460.
Margetić, Branimir
and
Aukst-Margetić, Branka
2007.
Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.
The World Journal of Biological Psychiatry,
Vol. 8,
Issue. 2,
p.
131.
Kosehasanogullari, Seyfullah Gorkem
Akdede, Berna
Akvardar, Yildiz
Akan, Mert
and
Tunca, Zeliha
2007.
Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 31,
Issue. 5,
p.
1147.
Kim, Jeong-Min
Lee, Soon-Tae
Song, Eun-Cheol
Jung, Keun-Hwa
Sinn, Dong-In
Chung, Hakjae
Chu, Kon
and
Kim, Manho
2007.
Neurotoxic Syndrome Developed after Taking Sertraline and Risperidone.
Journal of Clinical Neurology,
Vol. 3,
Issue. 3,
p.
165.
Tofade, Toyin S.
2009.
The Necessity of Considering Serotonin Toxicity as a Differential Diagnosis for NMS-Like Symptoms.
Journal of Pharmacy Practice,
Vol. 22,
Issue. 5,
p.
518.
Vurucu, Sebahattin
Congologlu, Ayhan
Altun, Demet
Unay, Bulent
and
Akin, Ridvan
2009.
Neuroleptic Malignant Syndrome Due to Risperidone Treatment in a Child With Joubert Syndrome.
Journal of the National Medical Association,
Vol. 101,
Issue. 3,
p.
273.
Gortney, Justine Schuller
Fagan, Alexandria
and
Kissack, Julie Cold
2009.
Neuroleptic Malignant Syndrome Secondary to Quetiapine.
Annals of Pharmacotherapy,
Vol. 43,
Issue. 4,
p.
785.
Cooper, Joyce M.
and
Jones, Alison L.
2009.
Neuroleptic Malignant Syndrome or a Statin Drug Reaction? A Case Report.
Clinical Neuropharmacology,
Vol. 32,
Issue. 6,
p.
348.
Unaldi, M
Sayhan, MB
Sogüt, O
Demirhan, R
and
Güzel, B
2010.
Neuroleptic Malignant Syndrome after the Addition of Lithium to Risperidone Treatment: A Case Report and Review of the Literature.
Hong Kong Journal of Emergency Medicine,
Vol. 17,
Issue. 3,
p.
289.
Havaki-Kontaxaki, Beata J.
Ferentinos, Panagiotis P.
Kontaxakis, Vassilis P.
Kontaxaki, Maria-Irini V.
Geronikola, Xenia
Armeniakos, Ioannis
and
Papadimitriou, George N.
2011.
Low-dose clozapine monotherapy for recurring episodes of depression, hypersomnia and behavioural disturbances: a case report.
Acta Neuropsychiatrica,
Vol. 23,
Issue. 4,
p.
191.
Wu, Yung-Fu
Kan, Yuk-Shing
and
Yang, Chen-Hong
2011.
Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease — a case report.
General Hospital Psychiatry,
Vol. 33,
Issue. 3,
p.
301.e7.
Nielsen, René Ernst
Jensen, Signe Olrik Wallenstein
and
Nielsen, Jimmi
2012.
Neuroleptic Malignant Syndrome—An 11-Year Longitudinal Case-Control Study.
The Canadian Journal of Psychiatry,
Vol. 57,
Issue. 8,
p.
512.
Kateon, Hayley
2013.
Differentiating serotonin syndrome and neuroleptic malignant syndrome.
Mental Health Clinician,
Vol. 3,
Issue. 3,
p.
129.
Christodoulou, Christos
Margaritis, Dimitris
Makris, Gerasimos
Kavatha, Dimitra
Efstathiou, Vasiliki
Papageorgiou, Charalabos
and
Douzenis, Athanasios
2015.
Quetiapine and Clarithromycin–Induced Neuroleptic Malignant Syndrome.
Clinical Neuropharmacology,
Vol. 38,
Issue. 1,
p.
36.
Sahin, Aynur
Cicek, Mustafa
Gonenc Cekic, Ozgen
Gunaydin, Mucahit
Aykut, Demet Saglam
Tatli, Ozgur
Karaca, Yunus
and
Arici, Mualla Aylin
2017.
A retrospective analysis of cases with neuroleptic malignant syndrome and an evaluation of risk factors for mortality.
Turkish Journal of Emergency Medicine,
Vol. 17,
Issue. 4,
p.
141.
Kollmann-Camaiora, A.
Alsina, E.
Domínguez, A.
del Blanco, B.
Yepes, M.J.
Guerrero, J.L.
and
García, A.
2017.
Protocolo clínico asistencial de manejo de la hipertermia maligna.
Revista Española de Anestesiología y Reanimación,
Vol. 64,
Issue. 1,
p.
32.
Kollmann-Camaiora, A.
Alsina, E.
Domínguez, A.
del Blanco, B.
Yepes, M.J.
Guerrero, J.L.
and
García, A.
2017.
Clinical protocol for the management of malignant hyperthermia.
Revista Española de Anestesiología y Reanimación (English Edition),
Vol. 64,
Issue. 1,
p.
32.